Health Recovery Solutions Buys Rimidi
In a move toward more integrated remote care, Health Recovery Solutions (HRS) has acquired Rimidi, a platform focused on chronic condition management. The deal signals a push for deeper EHR integration and expanded capabilities, especially in areas like continuous glucose monitoring and ambulatory care.
New York-based Health Recovery Solutions (HRS), founded in 2012, has raised a total of $84.7 million over 10 funding rounds. The company provides a remote monitoring and telehealth platform for healthcare providers, focusing on improving patient engagement to reduce hospital readmissions. The acquisition of Rimidi is a strategic move under the leadership of CEO Jason Comer, who was appointed in June 2024 after serving in various leadership roles within the company since 2017. Rimidi, founded in Atlanta by physician-scientist Dr. Lucienne Ide, specializes in software for chronic disease management. The company's platform integrates with electronic medical records to help clinicians manage chronic conditions by leveraging patient-generated data and clinical information. Rimidi has received strategic investments from entities like Cox Enterprises and Eli Lilly and Company. The integration of AI in chronic disease management is a key trend, with applications in predicting disease progression, personalizing treatment plans, and improving patient self-management. AI algorithms analyze data from wearables and apps to provide real-time insights for care teams, a capability central to the HRS and Rimidi combination. This market is seeing a surge in investment, with AI-enabled digital health startups attracting the majority of funding. For consumer health startups, a primary growth strategy is building trust through transparency and data privacy. While HIPAA generally doesn't cover most consumer health apps, the FTC's Health Breach Notification Rule requires companies to notify users of data breaches, including unauthorized data sharing. Successful apps often employ a multi-channel approach to user acquisition, including content marketing, SEO, and partnerships with healthcare providers. The digital health fundraising landscape is increasingly focused on early-stage investments in startups with scalable solutions, particularly in AI and remote patient monitoring. In 2025, U.S. digital health startups secured $14.2 billion, a significant increase from the previous year, with AI-focused companies raising substantially more per deal. This indicates strong investor confidence in technology-driven healthcare solutions. Wearable integration is a critical component for consumer health apps, with APIs from Apple, Fitbit, and others allowing for the collection of continuous health data. This data fuels the personalization algorithms that are becoming standard in chronic disease management. The market for wearable health technology is expanding beyond simple activity tracking to include medical-grade monitoring for conditions like heart arrhythmias and respiratory issues. The longevity and biohacking space is seeing significant investment in startups aiming to extend healthspan by targeting the cellular basis of aging. Companies like Altos Labs and Cambrian Bio are exploring cutting-edge science like epigenetic reprogramming. This reflects a broader consumer interest in proactive health and performance optimization, a key demographic for new wellness applications.
